|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
29,950,000 |
Market
Cap: |
92.55(M) |
Last
Volume: |
42,300 |
Avg
Vol: |
42,182 |
52
Week Range: |
$2.85 - $5.02 |
|
Level
I Sector: |
Information Technology |
Level
II Sector: |
Computer Hardware |
Level
III Sector: |
Computer Peripherals |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : 9.1 |
Insider 6 Months : 9.1 |
Insider 3/6 Months : 18.2 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Anixa Biosciences is a biotechnology company developing therapies and vaccines that are focused on unmet needs in oncology and infectious disease. Co.'s therapeutics programs include the development of a chimeric endocrine receptor T-cell therapy, a form of chimeric antigen receptor T-cell technology, initially focused on treating ovarian cancer and the discovery and development of anti-viral drug candidates for the treatment of Coronavirus disease 2019 focused on inhibiting certain protein functions of the virus. Co.'s vaccine programs include the development of a vaccine against triple negative breast cancer as well other forms of breast cancer and a vaccine against ovarian cancer.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
55,009 |
55,009 |
60,509 |
60,509 |
Total Buy Value |
$182,130 |
$182,130 |
$202,150 |
$202,150 |
Total People Bought |
3 |
3 |
4 |
4 |
Total Buy Transactions |
3 |
3 |
4 |
4 |
Total Shares Sold |
0 |
0 |
11,800 |
11,800 |
Total Sell Value |
$0 |
$0 |
$42,126 |
$42,126 |
Total People Sold |
0 |
0 |
1 |
1 |
Total Sell Transactions |
0 |
0 |
1 |
1 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Titterton Lewis H Jr |
Director |
|
2020-03-13 |
4 |
B |
$2.12 |
$12,294 |
D/D |
5,799 |
924,743 |
2.39 |
35% |
|
Baskies Arnold M |
Director |
|
2020-03-12 |
4 |
B |
$1.84 |
$18,400 |
D/D |
10,000 |
41,000 |
2.39 |
67% |
|
Kumar Amit |
Chief Executive Officer |
|
2020-03-12 |
4 |
B |
$1.82 |
$36,400 |
D/D |
20,000 |
214,000 |
2.81 |
67% |
|
Baskies Arnold M |
Director |
|
2020-03-06 |
4 |
B |
$2.71 |
$27,100 |
D/D |
10,000 |
31,000 |
2.39 |
6% |
|
Baskies Arnold M |
Director |
|
2020-01-17 |
4 |
B |
$3.53 |
$35,300 |
D/D |
10,000 |
21,000 |
2.39 |
-32% |
|
Titterton Lewis H Jr |
Director |
|
2020-01-15 |
4 |
B |
$3.32 |
$16,600 |
D/D |
5,000 |
918,944 |
2.39 |
-28% |
|
Titterton Lewis H Jr |
Director |
|
2020-01-14 |
4 |
B |
$3.22 |
$23,828 |
D/D |
7,400 |
913,944 |
2.39 |
-38% |
|
Kumar Amit |
Chief Executive Officer |
|
2020-01-14 |
4 |
B |
$2.99 |
$59,800 |
D/D |
20,000 |
194,000 |
2.81 |
-38% |
|
Catelani Michael |
COO & CFO |
|
2019-10-31 |
4 |
A |
$3.29 |
$3,000 |
D/D |
912 |
3,962 |
|
- |
|
Titterton Lewis H Jr |
Director |
|
2019-09-13 |
4 |
B |
$4.10 |
$61,500 |
D/D |
15,000 |
906,544 |
2.39 |
- |
|
Kumar Amit |
Chief Executive Officer |
|
2019-09-13 |
4 |
B |
$4.12 |
$41,200 |
D/D |
10,000 |
174,000 |
2.81 |
- |
|
36 Records found
|
|
Page 2 of 2 |
|
|